---
title: "GoodRx falls 5% as Q3 report delayed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305040477.md"
description: "GoodRx fell 5.48% to $3.45 after delaying its Q3 report due to an incomplete revenue restatement and expected material weaknesses."
datetime: "2026-11-10T15:56:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305040477.md)
  - [en](https://longbridge.com/en/news/305040477.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305040477.md)
generator: "portal-rs"
---

# GoodRx falls 5% as Q3 report delayed

GoodRx Holdings (GDRX.US) fell more than **5%** during regular trading to **$3.45**.

The health care technology industry index fell 1.2% over the same period.

The company announced a delay in filing its third-quarter 2026 Form 10-Q as the restatement of financial statements related to revenue recognition errors in the first and second quarters remains incomplete. GoodRx expects one or more material weaknesses in internal control over financial reporting and plans to file the delayed report within the five-day extension period.

Separately, GoodRx said on Oct. 27 it would restate first-half 2026 results after identifying that Pharma Direct revenue was understated and did not comply with ASC 606 requirements. The restatement is expected to increase total revenue by **$29.77 million** to **$424.19 million** and net income by **$14.85 million** to **$24.55 million** for the period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [GDRX.US](https://longbridge.com/en/quote/GDRX.US.md)

## Related News & Research

- [GoodRx delays third-quarter report as revenue restatement remains incomplete](https://longbridge.com/en/news/304998408.md)
- [GoodRx Brings Prescription Pricing Intelligence to Google Cloud’s Gemini for Healthcare | GDRX Stock News](https://longbridge.com/en/news/305017228.md)
- [Anthropic’s Valuation Target Has Slipped From $2 Trillion to Under $1.5 Trillion. Here’s Why](https://longbridge.com/en/news/305493732.md)
- [GoodRx (GDRX) Set to Release Quarterly Earnings on Tuesday](https://longbridge.com/en/news/303221675.md)
- [GoodRx to Restate First-Half 2026 Financials Over Understated Revenue](https://longbridge.com/en/news/304011602.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**